Fidelta: Selvita Expands Drug Discovery Services with Acquisition of Fidelta
Preclinical contract research organization (CRO) Selvita has entered into a deal with Galapagos to acquire its inflammation-, fibrosis- and anti-infectives-focused CRO Fidelta.
Read full article »
Fidelta is a contract research organization that provides drug discovery and development services for the pharmaceutical industry.
Read more